Pure Global AI
NCT06250361Not yet recruiting

Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease

Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease: the FAST Study
Groupe d'Etude Therapeutique des Affections Inflammatoires DigestivesClinicalTrials.govother
Verified
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
Questionnaire completion
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Timeline & enrollment
Phase
N/A
Start date
Feb 15, 2024
End date
Jun 15, 2025
Enrollment
600 participants
Primary outcome

Number of patient's visits to doctors between the appearance of the first symptoms and the diagnosis of the disease.,Number of exams performed between the appearance of the first symptoms and the diagnosis of the disease.,Number of medical specialties consulted between the appearance of the first symptoms and the diagnosis of the disease.

Summary

The goal of this observational study is to determine the factors associated with a delayed
 diagnosis and/or an immediately complicated disease for CD patients.
 
 A questionnaire will be completed by the patients, each questionnaire has a patient section
 and a physician section.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06250361
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06250361 through Pure Global AI's free database. This phase not specified trial is sponsored by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives and is currently Not yet recruiting. The study focuses on Crohn Disease. Target enrollment is 600 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.